ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the launch of ResQ215B, a Phase 2 ...

The study builds on data from an early-stage study which evaluated CD19 CAR-NK cell therapy in combination with the Rituximab ...

The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number ...

Explore the groundbreaking research on brain organoids that mimics glioblastoma in the human brain for better treatment ...

Twist Bioscience Corporation , a mid-cap growth and value biotech company, today announced financial results and business highlights for the first quarter fiscal 2026 ended December 31, 2025. Visit ...

The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being diagnosed with NSCLC, RCC, colorectal cancer ...

NAPCO Security Technologies, Inc. , one of the leading manufacturers and designers of high-tech electronic security equipment, wireless communication devices for intrusion and fire alarm systems and ...

This Research Topic is Volume II of a series. The previous volume, which has attracted over 21k views can be found here: New Tumor Immune Checkpoints and ...

Apple cider vinegar with honey may aid digestion, blood sugar, heart health, and weight management. Discover its uses, ...

Following an extraordinary surge in its share price of more than 200% during January, ImmunityBio now faces the critical task of justifying its elevated market ...

Diet and plant-derived bioactives are now recognized as active regulators of immune tone that link chronic metabolic dysfunction to cancer initiation, ...

By analyzing tissue from patients with Parkinson's disease, and animal and cellular models of the disease, a research team ...